BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19418968)

  • 1. Expression of secretoglobin3A2 (SCGB3A2) in primary pulmonary carcinomas.
    Tachihara-Yoshikawa M; Ishida T; Watanabe K; Sugawara A; Kanazawa K; Kanno R; Suzuki T; Niimi T; Kimura S; Munakata M
    Fukushima J Med Sci; 2008 Dec; 54(2):61-72. PubMed ID: 19418968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans.
    Kurotani R; Kumaki N; Naizhen X; Ward JM; Linnoila RI; Kimura S
    Lung Cancer; 2011 Jan; 71(1):42-8. PubMed ID: 20466451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of LH/FSH expression by secretoglobin 3A2 in the mouse pituitary gland.
    Miyano Y; Tahara S; Sakata I; Sakai T; Abe H; Kimura S; Kurotani R
    Cell Tissue Res; 2014 Apr; 356(1):253-60. PubMed ID: 24514953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.
    Kaufmann O; Dietel M
    Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
    Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
    Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trefoil factor 3 as a novel biomarker to distinguish between adenocarcinoma and squamous cell carcinoma.
    Wang XN; Wang SJ; Pandey V; Chen P; Li Q; Wu ZS; Wu Q; Lobie PE
    Medicine (Baltimore); 2015 May; 94(20):e860. PubMed ID: 25997063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice.
    Cai Y; Yoneda M; Tomita T; Kurotani R; Okamoto M; Kido T; Abe H; Mitzner W; Guha A; Kimura S
    BMC Pulm Med; 2015 Jul; 15():72. PubMed ID: 26178733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAATT/enhancer-binding proteins alpha and delta interact with NKX2-1 to synergistically activate mouse secretoglobin 3A2 gene expression.
    Tomita T; Kido T; Kurotani R; Iemura SI; Sterneck E; Natsume T; Vinson C; Kimura S
    J Biol Chem; 2008 Sep; 283(37):25617-25627. PubMed ID: 18632661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of secretoglobin 3A2 in lung development.
    Kurotani R; Tomita T; Yang Q; Carlson BA; Chen C; Kimura S
    Am J Respir Crit Care Med; 2008 Aug; 178(4):389-98. PubMed ID: 18535256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
    Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
    Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal Expression of Three Secretoglobin Proteins, SCGB1A1, SCGB3A1, and SCGB3A2, in Mouse Airway Epithelia.
    Naizhen X; Kido T; Yokoyama S; Linnoila RI; Kimura S
    J Histochem Cytochem; 2019 Jun; 67(6):453-463. PubMed ID: 30768367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosis.
    Cai Y; Winn ME; Zehmer JK; Gillette WK; Lubkowski JT; Pilon AL; Kimura S
    Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L10-22. PubMed ID: 24213919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid transcription factor 1 in pulmonary adenocarcinoma.
    Stenhouse G; Fyfe N; King G; Chapman A; Kerr KM
    J Clin Pathol; 2004 Apr; 57(4):383-7. PubMed ID: 15047742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
    Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
    Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretoglobin superfamily protein SCGB3A2 deficiency potentiates ovalbumin-induced allergic pulmonary inflammation.
    Kido T; Yoneda M; Cai Y; Matsubara T; Ward JM; Kimura S
    Mediators Inflamm; 2014; 2014():216465. PubMed ID: 25242865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretoglobin 3A2 suppresses bleomycin-induced pulmonary fibrosis by transforming growth factor beta signaling down-regulation.
    Kurotani R; Okumura S; Matsubara T; Yokoyama U; Buckley JR; Tomita T; Kezuka K; Nagano T; Esposito D; Taylor TE; Gillette WK; Ishikawa Y; Abe H; Ward JM; Kimura S
    J Biol Chem; 2011 Jun; 286(22):19682-92. PubMed ID: 21478551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
    Srodon M; Westra WH
    Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.